D. Gibb

发表

CLASP: a randomised trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women

Jeffrey R. Wilson, R. Collins, G. Swingler, 1994, The Lancet.

O222 Treatment interruption in children with chronic HIV-infection: the results of the paediatric European network for treatment of AIDS (PENTA) 11 trial

C. Giaquinto, F. Monpoux, D. Nadal, 2008 .

Regression of AIDS-related Kaposi's sarcoma during therapy with thalidomide.

R. Tedder, D. Nadal, N. Brink, 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Vertical transmission of Kaposi's sarcoma.

R. Miller, V. Novelli, D. Mercey, 1996, Archives of disease in childhood.

Paediatric European Network for Treatment of AIDS (PENTA) guidelines for treatment of paediatric HIV‐1 infection 2015: optimizing health in preparation for adult life

C. Giaquinto, N. Klein, D. Gibb, 2015, HIV medicine.

Nevirapine/zidovudine/lamivudine has superior immunological and virological responses not reflected in clinical outcomes in a 48‐week randomized comparison with abacavir/zidovudine/lamivudine in HIV‐infected Ugandan adults with low CD4 cell counts

C. Gilks, J. Darbyshire, D. Gibb, 2010, HIV medicine.

Oral abstracts of the 21st International AIDS Conference 18–22 July 2016, Durban, South Africa

Michael I. Jordan, Donald A. Jackson, J. G. Ndirangu, 2016, Journal of the International AIDS Society.

Improved Adherence to Antiretroviral Therapy Observed Among HIV-Infected Children Whose Caregivers had Positive Beliefs in Medicine in Sub-Saharan Africa

A. Walker, V. Mulenga, C. Kityo, 2016, AIDS and Behavior.

Antibody responses to Haemophilus influenzae type b and Streptococcus pneumoniae vaccines in children with human immunodeficiency virus infection.

C. Giaquinto, A. Giacomelli, S. Kroll, 1995, The Pediatric infectious disease journal.

Does early initiation of ART in infants affect virological and resistance outcomes? Data from the CHER trial after 6 years of follow-up

D. Pillay, L. Morris, K. Otwombe, 2012, Journal of the International AIDS Society.

Enhanced infection prophylaxis reduces mortality in severely immunosuppressed HIV-infected adults and older children initiating antiretroviral therapy in Kenya, Malawi, Uganda and Zimbabwe: the REALITY trial

K. Maitland, A. Siika, C. Kityo, 2016 .

Persistence of antibody responses to Haemophilus influenzae type b polysaccharide conjugate vaccine in children with vertically acquired human immunodeficiency virus infection.

C. Giaquinto, A. Giacomelli, D. Goldblatt, 1996, The Pediatric infectious disease journal.

Pharmacokinetics of zidovudine and dideoxyinosine alone and in combination in children with HIV infection.

D. Back, M. Barry, D. Gibb, 1995, British journal of clinical pharmacology.

Pharmacokinetics of Zidovudine in Children with Symptomatic HIV Infection

D. Back, M. Barry, D. Gibb, 1994 .

Early antiretroviral treatment reduces risk of bacille Calmette-Guérin immune reconstitution adenitis.

S. Madhi, M. Cotton, A. Babiker, 2011, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Respiratory morbidity from lymphocytic interstitial pneumonitis (LIP) in vertically acquired HIV infection

M. Sharland, D. Gibb, D. Gibb, 1997, Archives of disease in childhood.

Comparison of dual nucleoside-analogue reverse-transcriptase inhibitor regimens with and without nelfinavir in children with HIV-1 who have not previously been treated: the PENTA 5 randomised trial

C. Giaquinto, A. Walker, J. Darbyshire, 2002, The Lancet.

trialimmediate versus deferred zidovudine: the PENTA 1 in a randomised double blind controlled trial of Five year follow up of vertically HIV infected children

Saidi, Giaquinto, D. Gibb, 2001 .

Tenofovir disoproxil fumarate in pregnancy and prevention of mother‐to‐child transmission of HIV‐1: is it time to move on from zidovudine?

D. Gibb, H. Lyall, G. Pearce, 2009, HIV medicine.

Kawasaki disease: a disorder looking for an organism?

D. Gibb, 1991, Paediatric and perinatal epidemiology.

Mother-to-child transmission of hepatitis C virus: evidence for preventable peripartum transmission

D. Gibb, K. Butler, P. Neave, 2000, The Lancet.

Co-trimoxazole as prophylaxis against opportunistic infections in HIV-infected Zambian children (CHAP): a double-blind randomised placebo-controlled trial

Alimuddin Zumla, V. Mulenga, C. Chintu, 2004, The Lancet.

Bovine colostrum immunoglobulin concentrate for cryptosporidiosis in AIDS.

V. Novelli, D. Gibb, P. Milla, 1993, Archives of disease in childhood.

Immune repopulation after HAART in previously untreated HIV-1-infected children

N. Klein, D. Gibb, A. Babiker, 2000, The Lancet.

PENTA guidelines for the use of antiretroviral therapy in paediatric HIV infection

M. Sharland, D. Gibb, S. Blanche, 2002, HIV medicine.

Acceptability of a first-line anti-tuberculosis formulation for children: qualitative data from the SHINE trial

A. Crook, J. Seeley, M. M. van der Zalm, 2019, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

PENTA guidelines for the use of antiretroviral therapy, 2004

M. Sharland, D. Gibb, S. Blanche, 2004, HIV medicine.

Lamivudine/abacavir maintains virological superiority over zidovudine/lamivudine and zidovudine/abacavir beyond 5 years in children

D. Pillay, C. Giaquinto, A. Walker, 2007, AIDS.

Strategies for nevirapine initiation in HIV-infected children taking pediatric fixed-dose combination "baby pills" in Zambia: a randomized controlled trial.

C. Kankasa, V. Mulenga, C. Chintu, 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Highly active antiretroviral therapy started in infants under 3 months of age: 72-week follow-up for CD4 cell count, viral load and drug resistance outcome

C. Giaquinto, J. Darbyshire, A. Babiker, 2004, AIDS.

Kaposi's sarcoma and KSHV

S. Franceschi, D. Serraino, D. Shingadia, 1995, The Lancet.

The EPIICAL project: an emerging global collaboration to investigate immunotherapeutic strategies in HIV-infected children

V. Calvez, D. Pillay, C. Giaquinto, 2015, Journal of virus eradication.